Haselmeier Announces Market Launch of JuniorSTAR by Sanofi
The new and reusable half-unit insulin pen JuniorSTAR is now available in Germany. It is suitable for all insulin types of Sanofi. It provides individual dosage, which can be corrected easily. Furthermore, it has a large display to ensure the correct dosage and is a lightweight companion during the day, especially for young people with diabetes.
“The launch of JuniorSTAR marks another milestone of a long-term partnership with Sanofi. After the single unit pen TactiPen, the portfolio is now completed by the half-unit pen JuniorSTAR. The JuniorSTAR delivers 1 to 30 units in steps of 0.5. Thanks to the close cooperation of both teams, we were able to develop an excellent pen that meets the current very high-quality requirements,” explains Sandra de Haan, Director Project Management at Haselmeier and responsible project manager for the JuniorSTAR project.
“The JuniorSTAR expands our individual portfolio for people suffering from diabetes. This pen offers, especially young people with type 1 diabetes, flexible and easy handling to lighten their lives with diabetes. The excellent and close cooperation with Haselmeier was an important part for the successful development of the JuniorSTAR pen,” adds Hamid Oualali, Global Device Manager for reusable pens at Sanofi.
This pen comes in red, blue, and silver for more flexibility and easy differentiation of various insulin types. The Chicago Athenaeum, Museum of Architecture and Design already honoured the JuniorSTAR pen for its new and fully developed technology with the Good Design Award.
Sanofi-Aventis Deutschland GmbH is a company of the Sanofi Group, a global healthcare leader, which discovers, develops, and distributes therapeutic solutions to meet the patients’ needs. Sanofi has its core strengths in the field of healthcare with seven growth platforms: diabetes solutions, vaccines, innovative medication, over-the-counter healthcare products, emerging markets, animal health, and Genzyme.
Founded in Stuttgart in 1920, Haselmeier is now one of the leading designers and
manufacturers of injection systems. The devices feature unique function, design, and technology and are marketed by leading pharmaceutical and biotechnology companies around the world. Located in five locations across three continents, the company develops and produces innovative technologies for administering medication to improve the health and everyday life of patients. For more information, visit www.haselmeier.com.
Total Page Views: 1334
